Listed by the USPTO as GRASER, JENNIFER E
Tech Center 1600 • Art Units: 1633 1645
This examiner grants 77% of resolved cases
GRASER, JENNIFER E is a USPTO patent examiner in Tech Center 1600 and art unit 1633. The profile covers 1053 resolved cases, with an allowance rate of 76.8% and a median of 887 days to allowance. Interviews show a lift of 23.2%, indicating a positive association with allowance in the recorded matters.
The leading companies are CJ CheilJedang Corporation, University of Massachusetts, and Zoetis LLC. The listed firms are MARSHALL, GERSTEIN & BORUN LLP, MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP, and ARMSTRONG TEASDALE LLP (15060). The extensive record supports detailed review of successful prosecution tactics, and the median time indicates that applications reaching allowance generally did so without the longest delays in this dataset.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19644831 | MICROORGANISM HAVING FOREIGN NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE INTRODUCED THEREINTO AND METHOD FOR PRODUCING L-AMINO ACID OR DERIVATIVE THEREOF USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18851628 | ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER | Non-Final OA | University of Massachusetts |
| 19054649 | ATTENUATED BORDETELLA BRONCHISEPTICA STRAINS, ORAL VACCINES CONTAINING THE ATTENUATED STRAINS, AND METHODS OF MAKING & USE THEREOF | Non-Final OA | Boehringer Ingelheim Animal Health USA Inc. |
| 17620633 | BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T-CELLS | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18845468 | ATTENUATED MATURATION-DEFECTIVE CHLAMYDIA VACCINES | Non-Final OA | Rutgers, The State University of New Jersey |
| 18895960 | STRAINS, COMPOSITIONS AND METHODS OF USE | Non-Final OA | L'Oreal S.A. |
| 18941161 | COMPOSITIONS OF VACCINES AGAINST CLOSTRIDIAL DERMATITIS AND METHODS OF USE THEREOF | Non-Final OA | NORTH CAROLINA STATE UNIVERSITY |
| 18684124 | COMPOSITIONS AND METHODS FOR GENERATING TICK IMMUNITY | Non-Final OA | Yale University |
| 18270947 | NOVEL COMPOSITION | Final Rejection | The University of Liverpool |
| 19013202 | SELF-ADJUVANTING YERSINIA OUTER MEMBRANE VESICLE AS A VACCINE AGAINST PLAGUE, ANTHRAX AND PSEUDOMONAS INFECTION | Non-Final OA | Individual inventor |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy76.8% of resolved applications examined by Jennifer E Graser were allowed (1,053 resolved cases), compared with 34.8% across Art Unit 1633 over the last five years.
This examiner's interview lift is +23.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jennifer E Graser took 887 days on average from filing to allowance.
Jennifer E Graser examines applications in Art Unit 1633 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
